Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism
Journal of Affective Disorders Nov 18, 2017
Paulzen M, et al. - This study was performed to explore the pharmacokinetic interactions between venlafaxine and doxepin or mirtazapine in a naturalistic sample. An inhibiting effect of doxepin on the metabolism of venlafaxine was implied by higher concentrations of venlafaxine (VEN) and AM, even though the huge variability of concentrations had to be taken into account. Monitoring plasma concentrations in combination treatment were recommended to avoid problems in safety and efficacy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries